BGLC
BioNexus Gene Lab Corp Common stockNASDAQBASIC MATERIALSSPECIALTY CHEMICALS
Key Statistics
Market Cap
$5.35M
P/E Ratio
—
EPS
$-1.28
Beta
2.31
52W High
$15.60
52W Low
$1.92
50-Day MA
$2.42
200-Day MA
$4.28
Dividend Yield
—
Profit Margin
-24.30%
Forward P/E
—
PEG Ratio
—
About BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp. The company is headquartered in Kuala Lumpur, Malaysia.
Fundamentals
| Revenue (TTM) | $9.46M |
| Gross Profit (TTM) | $1.40M |
| EBITDA | $-2.33M |
| Operating Margin | -30.30% |
| Return on Equity | -28.30% |
| Return on Assets | -16.40% |
| Revenue/Share (TTM) | $5.27 |
| Book Value | $3.79 |
| Price-to-Book | 0.77 |
| Price-to-Sales (TTM) | 0.56 |
| EV/Revenue | 0.265 |
| EV/EBITDA | 629.53 |
| Quarterly Earnings Growth (YoY) | -95.00% |
| Quarterly Revenue Growth (YoY) | -3.30% |
| Shares Outstanding | $2.36M |
| Float | $1.29M |
| % Insiders | 36.39% |
| % Institutions | 2.02% |
Data last updated: 4/7/2026